NCT02237443View on ClinicalTrials.gov

Mask Ventilation Before and After Neuromuscular Blockade

PHASE4CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

February 28, 2015

Conditions
Anesthesia
Interventions
DRUG

Rocuronium

Administration of a NMBD

DRUG

Vecuronium Bromide

Administration of a NMBD

DRUG

Succinylcholine

Administration of a NMBD

Trial Locations (1)

98104

Harborview Medical Center, Seattle

All Listed Sponsors
lead

University of Washington

OTHER

NCT02237443 - Mask Ventilation Before and After Neuromuscular Blockade | Biotech Hunter | Biotech Hunter